Loss of ARID1A activates mTOR signaling and SOX9 in gastric adenocarcinoma-rationale for targeting ARID1A deficiency. Dong X, Song S, Li Y, Fan Y, et al. Gut 2022;71:467-478.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dong X, Song S, Li Y, Fan Y, et al. Loss of ARID1A activates mTOR signaling and SOX9 in gastric adenocarcinoma-rationale for targeting ARID1A deficiency. Gut 2022;71:467-478.
PMID: 33785559